Summary of Findings
hypertension
SECONDARY, HYPERTENSION, RECRUITMENT
The MyHEART study represents successful recruitment, enrollment, and engagement of racially and geographically diverse young adults. The trial did not demonstrate a significant change between study groups in systolic or diastolic BP or the secondary outcome of hypertension control at 6 or 12 months. However, both study groups demonstrated an overall decrease in systolic and diastolic BPs at 6 and 12 months. The interval change in clinic and 24-hour AMBP systolic and diastolic from baseline to 6 and 12 months was evaluated, and we found the intervention group had a significant reduction in all 6- and 12-month BP values except the 12-month 24-hour AMBP results in comparison with the baseline values. The control group demonstrated a significant reduction in all of the clinic BP values and only the systolic 24-hour AMBP result at 6 months. Compared with the control group, intervention participants demonstrated a significant increase in physical activity, reduction in dietary sodium intake, and increase in home BP monitoring at 6 months. The increase in physical activity and reduction in dietary sodium intake was not maintained at 12 months. Participants still had an increase in performing home BP monitoring at 12 months, albeit at a lower rate.